Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: Evidence from randomized controlled trials

Journal of the American Society of Hypertension

Volumn 8, Issue 5, 2014, Pages 340-349

  Wang, Ji Guang ^a   Yan, Ping ^b   Jeffers, Barrett W ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PFIZER INC   (United States)

Author keywords

Blood pressure variability; calcium channel blockers; hypertension; meta analysis; trial

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; LOSARTAN;

AGE; BLOOD PRESSURE VARIABILITY; DRUG EFFECT; HEALTH SERVICE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DRUG EFFECTS; HYPERTENSION;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHLORTHALIDONE; ENALAPRIL; HUMANS; HYPERTENSION; LISINOPRIL; LOSARTAN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84901203642     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.02.004     Document Type: Review

References (21)

1. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
2. NICE Guidance. Hypertension. Management of hypertension in primary care (CG127). Available at: http://guidance.nice.org.uk/CG127. Accessed January 17, 2013.
3. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 2007 1462 1536
4. E. O'Brien, R. Asmar, L. Beilin, Y. Imai, G. Mancia, and T. Mengden et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement J Hypertens 23 2005 697 701
5. G. Parati, G.S. Stergiou, R. Asmar, G. Bilo, P. de Leeuw, and Y. Imai et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring J Hypertens 26 2008 1505 1526
6. T.G. Pickering, J.E. Hall, L.J. Appel, B.E. Falkner, J. Graves, and M.N. Hill et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Circulation 111 2005 697 716
7. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
8. G. Parati, J.E. Ochoa, C. Lombardi, and G. Bilo Assessment and management of blood-pressure variability Nat Rev Cardiol 10 2013 143 155
9. P.M. Rothwell Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension Lancet 375 2010 938 948
10. G. Parati, G. Pomidossi, F. Albini, D. Malaspina, and G. Mancia Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension J Hypertens 5 1987 93 98
11. A.M. Brickman, C. Reitz, J.A. Luchsinger, J.J. Manly, N. Schupf, and J. Muraskin et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort Arch Neurol 67 2010 564 569
12. P. Muntner, D. Shimbo, M. Tonelli, K. Reynolds, D.K. Arnett, and S. Oparil The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994 Hypertension 57 2011 160 166
13. S. Kes, N. Caglar, A. Canberk, N. Deger, M. Demirtas, and H. Dortlemez et al. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine Curr Med Res Opin 19 2003 226 237
14. Y. Zhang, D. Agnoletti, M.E. Safar, and J. Blacher Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study Hypertension 58 2011 155 160
15. P.M. Rothwell, S.C. Howard, E. Dolan, E. O'Brien, J.E. Dobson, and B. Dahlöf et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke Lancet Neurol 9 2010 469 480
16. B. Dahlöf, P.S. Sever, N.R. Poulter, H. Wedel, D.G. Beevers, and M. Caulfield et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Lancet 366 2005 895 906
17. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
18. S.E. Nissen, E.M. Tuzcu, P. Libby, P.D. Thompson, M. Ghali, and D. Garza et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial JAMA 292 2004 2217 2225
19. A. Whitehead Meta-Analysis of Controlled Clinical Trials 2002 John Wiley & Sons, Ltd Chichester, England
20. S.L. Normand Tutorial in biostatistics. Meta-analysis: formulating, evaluating, combining, and reporting Stat Med 18 1999 321 359
21. Z.B. Wu, Y. Zhang, Q.G. Yu, C.X. Sun, and C.W. Tao Effects of valsartan combined with amlodipine or hydrochlorothiazide regimen on blood pressure variation in elderly hypertensive patients Zhonghua Xin Xue Guan Bing Za Zhi 40 2012 8 13